Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Wellington Management
Pharma
Could proxy advisers sway votes against BMS-Celgene merger?
Proxy advisers will soon weigh in on BMS' $74 billion Celgene buyout, and their verdicts could sway undecided shareholders, analysts say.
Arlene Weintraub
Mar 21, 2019 11:51am
Without 'smoking gun,' BMS, Celgene deal will close: analyst
Mar 19, 2019 12:29pm
Could a Celgene patent dispute tank the BMS deal?
Mar 13, 2019 11:23am
Activist steps up revolt on BMS-Celgene merger
Mar 6, 2019 11:30am
Can BMS rebels scuttle its Celgene buy? Analysts do the math
Mar 1, 2019 11:18am
Starboard joins BMS' largest investor in condemning Celgene buy
Feb 27, 2019 9:55pm
